Global Colorectal Cancer Diagnostics & Therapeutics Market Size, Status and Forecast 2024-2031

Report ID: 923009 | Published Date: Jan 2025 | No. of Page: 126 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Colorectal Cancer Diagnostics
        1.2.3 Colorectal Cancer Therapeutics
    1.3 Market by Application
        1.3.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Specialty Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Perspective (2016-2027)
    2.2 Colorectal Cancer Diagnostics & Therapeutics Growth Trends by Regions
        2.2.1 Colorectal Cancer Diagnostics & Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Colorectal Cancer Diagnostics & Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Colorectal Cancer Diagnostics & Therapeutics Industry Dynamic
        2.3.1 Colorectal Cancer Diagnostics & Therapeutics Market Trends
        2.3.2 Colorectal Cancer Diagnostics & Therapeutics Market Drivers
        2.3.3 Colorectal Cancer Diagnostics & Therapeutics Market Challenges
        2.3.4 Colorectal Cancer Diagnostics & Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Colorectal Cancer Diagnostics & Therapeutics Players by Revenue
        3.1.1 Global Top Colorectal Cancer Diagnostics & Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Colorectal Cancer Diagnostics & Therapeutics Revenue
    3.4 Global Colorectal Cancer Diagnostics & Therapeutics Market Concentration Ratio
        3.4.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Diagnostics & Therapeutics Revenue in 2020
    3.5 Colorectal Cancer Diagnostics & Therapeutics Key Players Head office and Area Served
    3.6 Key Players Colorectal Cancer Diagnostics & Therapeutics Product Solution and Service
    3.7 Date of Enter into Colorectal Cancer Diagnostics & Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Colorectal Cancer Diagnostics & Therapeutics Breakdown Data by Type
    4.1 Global Colorectal Cancer Diagnostics & Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Type (2022-2027)

5 Colorectal Cancer Diagnostics & Therapeutics Breakdown Data by Application
    5.1 Global Colorectal Cancer Diagnostics & Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size (2016-2027)
    6.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
        6.2.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2027)
    6.3 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
        6.3.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2027)
    6.4 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country
        6.4.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size (2016-2027)
    7.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
        7.2.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
        7.3.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country
        7.4.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size (2016-2027)
    9.2 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
        9.2.1 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
        9.3.1 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country
        9.4.1 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Biocept
        11.1.1 Biocept Company Details
        11.1.2 Biocept Business Overview
        11.1.3 Biocept Colorectal Cancer Diagnostics & Therapeutics Introduction
        11.1.4 Biocept Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        11.1.5 Biocept Recent Development
    11.2 Cancer Genetics
        11.2.1 Cancer Genetics Company Details
        11.2.2 Cancer Genetics Business Overview
        11.2.3 Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Introduction
        11.2.4 Cancer Genetics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        11.2.5 Cancer Genetics Recent Development
    11.3 Foundation Medicine
        11.3.1 Foundation Medicine Company Details
        11.3.2 Foundation Medicine Business Overview
        11.3.3 Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Introduction
        11.3.4 Foundation Medicine Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        11.3.5 Foundation Medicine Recent Development
    11.4 Sysmex Corporation
        11.4.1 Sysmex Corporation Company Details
        11.4.2 Sysmex Corporation Business Overview
        11.4.3 Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
        11.4.4 Sysmex Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        11.4.5 Sysmex Corporation Recent Development
    11.5 Danaher Corporation
        11.5.1 Danaher Corporation Company Details
        11.5.2 Danaher Corporation Business Overview
        11.5.3 Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
        11.5.4 Danaher Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        11.5.5 Danaher Corporation Recent Development
    11.6 Epigenomics
        11.6.1 Epigenomics Company Details
        11.6.2 Epigenomics Business Overview
        11.6.3 Epigenomics Colorectal Cancer Diagnostics & Therapeutics Introduction
        11.6.4 Epigenomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        11.6.5 Epigenomics Recent Development
    11.7 Illumina
        11.7.1 Illumina Company Details
        11.7.2 Illumina Business Overview
        11.7.3 Illumina Colorectal Cancer Diagnostics & Therapeutics Introduction
        11.7.4 Illumina Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        11.7.5 Illumina Recent Development
    11.8 Rosetta Genomics
        11.8.1 Rosetta Genomics Company Details
        11.8.2 Rosetta Genomics Business Overview
        11.8.3 Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Introduction
        11.8.4 Rosetta Genomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        11.8.5 Rosetta Genomics Recent Development
    11.9 Exact Science Corporation
        11.9.1 Exact Science Corporation Company Details
        11.9.2 Exact Science Corporation Business Overview
        11.9.3 Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
        11.9.4 Exact Science Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        11.9.5 Exact Science Corporation Recent Development
    11.10 Pathway Genomics Corporation
        11.10.1 Pathway Genomics Corporation Company Details
        11.10.2 Pathway Genomics Corporation Business Overview
        11.10.3 Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
        11.10.4 Pathway Genomics Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        11.10.5 Pathway Genomics Corporation Recent Development
    11.11 Taiho Pharma
        11.11.1 Taiho Pharma Company Details
        11.11.2 Taiho Pharma Business Overview
        11.11.3 Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Introduction
        11.11.4 Taiho Pharma Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        11.11.5 Taiho Pharma Recent Development
    11.12 Merck KGaA
        11.12.1 Merck KGaA Company Details
        11.12.2 Merck KGaA Business Overview
        11.12.3 Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Introduction
        11.12.4 Merck KGaA Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        11.12.5 Merck KGaA Recent Development
    11.13 Amgen
        11.13.1 Amgen Company Details
        11.13.2 Amgen Business Overview
        11.13.3 Amgen Colorectal Cancer Diagnostics & Therapeutics Introduction
        11.13.4 Amgen Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        11.13.5 Amgen Recent Development
    11.14 Takeda
        11.14.1 Takeda Company Details
        11.14.2 Takeda Business Overview
        11.14.3 Takeda Colorectal Cancer Diagnostics & Therapeutics Introduction
        11.14.4 Takeda Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        11.14.5 Takeda Recent Development
    11.15 Roche
        11.15.1 Roche Company Details
        11.15.2 Roche Business Overview
        11.15.3 Roche Colorectal Cancer Diagnostics & Therapeutics Introduction
        11.15.4 Roche Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        11.15.5 Roche Recent Development
    11.16 Eli Lilly
        11.16.1 Eli Lilly Company Details
        11.16.2 Eli Lilly Business Overview
        11.16.3 Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Introduction
        11.16.4 Eli Lilly Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        11.16.5 Eli Lilly Recent Development
    11.17 Sanofi
        11.17.1 Sanofi Company Details
        11.17.2 Sanofi Business Overview
        11.17.3 Sanofi Colorectal Cancer Diagnostics & Therapeutics Introduction
        11.17.4 Sanofi Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        11.17.5 Sanofi Recent Development
    11.18 Regeneron
        11.18.1 Regeneron Company Details
        11.18.2 Regeneron Business Overview
        11.18.3 Regeneron Colorectal Cancer Diagnostics & Therapeutics Introduction
        11.18.4 Regeneron Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        11.18.5 Regeneron Recent Development
    11.18 Bayer
        .1 Bayer Company Details
        .2 Bayer Business Overview
        .3 Bayer Colorectal Cancer Diagnostics & Therapeutics Introduction
        .4 Bayer Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        .5 Bayer Recent Development
    11.20 Onyx
        11.20.1 Onyx Company Details
        11.20.2 Onyx Business Overview
        11.20.3 Onyx Colorectal Cancer Diagnostics & Therapeutics Introduction
        11.20.4 Onyx Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
        11.20.5 Onyx Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Colorectal Cancer Diagnostics
    Table 3. Key Players of Colorectal Cancer Therapeutics
    Table 4. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Regions (2016-2021)
    Table 8. Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Regions (2022-2027)
    Table 10. Colorectal Cancer Diagnostics & Therapeutics Market Trends
    Table 11. Colorectal Cancer Diagnostics & Therapeutics Market Drivers
    Table 12. Colorectal Cancer Diagnostics & Therapeutics Market Challenges
    Table 13. Colorectal Cancer Diagnostics & Therapeutics Market Restraints
    Table 14. Global Colorectal Cancer Diagnostics & Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Players (2016-2021)
    Table 16. Global Top Colorectal Cancer Diagnostics & Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Diagnostics & Therapeutics as of 2020)
    Table 17. Ranking of Global Top Colorectal Cancer Diagnostics & Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Colorectal Cancer Diagnostics & Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Colorectal Cancer Diagnostics & Therapeutics Product Solution and Service
    Table 21. Date of Enter into Colorectal Cancer Diagnostics & Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Type (2016-2021)
    Table 25. Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Application (2016-2021)
    Table 29. Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Biocept Company Details
    Table 62. Biocept Business Overview
    Table 63. Biocept Colorectal Cancer Diagnostics & Therapeutics Product
    Table 64. Biocept Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 65. Biocept Recent Development
    Table 66. Cancer Genetics Company Details
    Table 67. Cancer Genetics Business Overview
    Table 68. Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Product
    Table 69. Cancer Genetics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 70. Cancer Genetics Recent Development
    Table 71. Foundation Medicine Company Details
    Table 72. Foundation Medicine Business Overview
    Table 73. Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Product
    Table 74. Foundation Medicine Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 75. Foundation Medicine Recent Development
    Table 76. Sysmex Corporation Company Details
    Table 77. Sysmex Corporation Business Overview
    Table 78. Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Product
    Table 79. Sysmex Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 80. Sysmex Corporation Recent Development
    Table 81. Danaher Corporation Company Details
    Table 82. Danaher Corporation Business Overview
    Table 83. Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Product
    Table 84. Danaher Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 85. Danaher Corporation Recent Development
    Table 86. Epigenomics Company Details
    Table 87. Epigenomics Business Overview
    Table 88. Epigenomics Colorectal Cancer Diagnostics & Therapeutics Product
    Table 89. Epigenomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 90. Epigenomics Recent Development
    Table 91. Illumina Company Details
    Table 92. Illumina Business Overview
    Table 93. Illumina Colorectal Cancer Diagnostics & Therapeutics Product
    Table 94. Illumina Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 95. Illumina Recent Development
    Table 96. Rosetta Genomics Company Details
    Table 97. Rosetta Genomics Business Overview
    Table 98. Rosetta Genomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 99. Rosetta Genomics Recent Development
    Table 100. Exact Science Corporation Company Details
    Table 101. Exact Science Corporation Business Overview
    Table 102. Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Product
    Table 103. Exact Science Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 104. Exact Science Corporation Recent Development
    Table 105. Pathway Genomics Corporation Company Details
    Table 106. Pathway Genomics Corporation Business Overview
    Table 107. Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Product
    Table 108. Pathway Genomics Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 109. Pathway Genomics Corporation Recent Development
    Table 110. Taiho Pharma Company Details
    Table 111. Taiho Pharma Business Overview
    Table 112. Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Product
    Table 113. Taiho Pharma Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 114. Taiho Pharma Recent Development
    Table 115. Merck KGaA Company Details
    Table 116. Merck KGaA Business Overview
    Table 117. Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Product
    Table 118. Merck KGaA Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 119. Merck KGaA Recent Development
    Table 120. Amgen Company Details
    Table 121. Amgen Business Overview
    Table 122. Amgen Colorectal Cancer Diagnostics & Therapeutics Product
    Table 123. Amgen Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 124. Amgen Recent Development
    Table 125. Takeda Company Details
    Table 126. Takeda Business Overview
    Table 127. Takeda Colorectal Cancer Diagnostics & Therapeutics Product
    Table 128. Takeda Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 129. Takeda Recent Development
    Table 130. Roche Company Details
    Table 131. Roche Business Overview
    Table 132. Roche Colorectal Cancer Diagnostics & Therapeutics Product
    Table 133. Roche Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 134. Roche Recent Development
    Table 135. Eli Lilly Company Details
    Table 136. Eli Lilly Business Overview
    Table 137. Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Product
    Table 138. Eli Lilly Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 139. Eli Lilly Recent Development
    Table 140. Sanofi Company Details
    Table 141. Sanofi Business Overview
    Table 142. Sanofi Colorectal Cancer Diagnostics & Therapeutics Product
    Table 143. Sanofi Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 144. Sanofi Recent Development
    Table 145. Regeneron Company Details
    Table 146. Regeneron Business Overview
    Table 147. Regeneron Colorectal Cancer Diagnostics & Therapeutics Product
    Table 148. Regeneron Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 149. Regeneron Recent Development
    Table 150. Bayer Company Details
    Table 151. Bayer Business Overview
    Table 152. Bayer Colorectal Cancer Diagnostics & Therapeutics Product
    Table 153. Bayer Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 154. Bayer Recent Development
    Table 155. Onyx Company Details
    Table 156. Onyx Business Overview
    Table 157. Onyx Colorectal Cancer Diagnostics & Therapeutics Product
    Table 158. Onyx Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
    Table 159. Onyx Recent Development
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Colorectal Cancer Diagnostics Features
    Figure 3. Colorectal Cancer Therapeutics Features
    Figure 4. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Application: 2020 VS 2027
    Figure 5. Hospitals Case Studies
    Figure 6. Specialty Clinics Case Studies
    Figure 7. Others Case Studies
    Figure 8. Colorectal Cancer Diagnostics & Therapeutics Report Years Considered
    Figure 9. Global Colorectal Cancer Diagnostics & Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Colorectal Cancer Diagnostics & Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 12. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Regions (2022-2027)
    Figure 13. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Players in 2020
    Figure 14. Global Top Colorectal Cancer Diagnostics & Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Diagnostics & Therapeutics as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Colorectal Cancer Diagnostics & Therapeutics Revenue in 2020
    Figure 16. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 17. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 18. North America Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2016-2027)
    Figure 20. North America Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2016-2027)
    Figure 21. North America Colorectal Cancer Diagnostics & Therapeutics Market Share by Country (2016-2027)
    Figure 22. United States Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2016-2027)
    Figure 26. Europe Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2016-2027)
    Figure 27. Europe Colorectal Cancer Diagnostics & Therapeutics Market Share by Country (2016-2027)
    Figure 28. Germany Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Share by Region (2016-2027)
    Figure 38. China Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2016-2027)
    Figure 46. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2016-2027)
    Figure 47. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Share by Country (2016-2027)
    Figure 48. Mexico Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Share by Country (2016-2027)
    Figure 54. Turkey Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Biocept Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 58. Cancer Genetics Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 59. Foundation Medicine Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 60. Sysmex Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 61. Danaher Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 62. Epigenomics Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 63. Illumina Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 64. Rosetta Genomics Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 65. Exact Science Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 66. Pathway Genomics Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 67. Taiho Pharma Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 68. Merck KGaA Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 69. Amgen Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 70. Takeda Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 71. Roche Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 72. Eli Lilly Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 73. Sanofi Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 74. Regeneron Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 75. Bayer Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 76. Onyx Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Biocept
Cancer Genetics
Foundation Medicine
Sysmex Corporation
Danaher Corporation
Epigenomics
Illumina
Rosetta Genomics
Exact Science Corporation
Pathway Genomics Corporation
Taiho Pharma
Merck KGaA
Amgen
Takeda
Roche
Eli Lilly
Sanofi
Regeneron
Bayer
Onyx
Frequently Asked Questions
Colorectal Cancer Diagnostics & Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Colorectal Cancer Diagnostics & Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Colorectal Cancer Diagnostics & Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Vermox

Market Analysis and Insights: Global Vermox Market
The global Vermox market size is ... Read More